Results 31 - 40 of 503 : Previous 1 2 3 4 5 6 7 8 9 Next
Small and Volatile, but Not for Long
BioMarin is growing.
Winning With Buy-and-Hold Mutual Funds
These fund managers may be onto something.
Uncover the Market's Best Bargains
There's always value out there. The trick is finding it.
Pfizer's and Merck's Loss Is These Companies' Gain
Too busy integrating to take advantage of additional acquisitions.
8 of the Most Efficient Companies on the Planet
These companies work smarter, not harder.
These Companies Could Be Takeover Targets
Strong brands and international exposure could draw a bid for these names.
Another delay for Prolia.
The Heart Company's Disheartening Forecast
Boston Scientific scaled back its full-year forecast, and the market doesn't like it.
Expect it to continue.
Don't get too excited, though.